Transcriptional regulation by post-transcriptional modification-Role of phosphorylation in Sp1 transcriptional activity

Gene

Volumn 508, Issue 1, 2012, Pages 1-8

  Chu, Shijian ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Gene expression; Kinase; Phosphatase; Signal transduction pathway; Transcription factor

Indexed keywords

ANGIOTENSIN II; GLUCOSE; INSULIN; PHOSPHATASE; TRANSCRIPTION FACTOR SP1;

BINDING AFFINITY; CELL FUNCTION; CELL GROWTH; CHEMICAL MODIFICATION; DNA BINDING; DNA MODIFICATION; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIVER CANCER; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW; SHEAR STRESS; TRANSCRIPTION REGULATION; VIRUS INFECTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; RNA PROCESSING, POST-TRANSCRIPTIONAL; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84865574311     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.022     Document Type: Review

References (102)

1. Amin M.R., Malakooti J., Sandoval R., Dudeja P.K., Ramaswamy K. IFN-gamma and TNF-alpha regulate human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line C2BBe1. Am. J. Physiol. Cell Physiol. 2006, 291:C887-C896.
2. Armstrong S.A., Barry D.A., Leggett R.W., Mueller C.R. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 1997, 272:13489-13495.
3. Bakovic M., Waite K., Vance D.E. Oncogenic Ha-Ras transformation modulates the transcription of the CTP:phosphocholine cytidylyltransferase alpha gene via p42/44MAPK and transcription factor Sp3. J. Biol. Chem. 2003, 278:14753-14761.
4. Benasciutti E., Pages G., Kenzior O., Folk W., Blasi F., Crippa M.P. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 2004, 104:256-262.
5. Black A.R., Jensen D., Lin S.Y., Azizkhan J.C. Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 1999, 274:1207-1215.
6. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 2001, 188:143-160.
7. Bonello M.R., Khachigian L.M. Fibroblast growth factor-2 represses platelet-derived growth factor receptor-alpha (PDGFR-alpha) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-alpha promoter. J. Biol. Chem. 2004, 279:2377-2382.
8. Brasse-Lagnel C., et al. Glutamine and interleukin-1beta interact at the level of Sp1 and nuclear factor-kappaB to regulate argininosuccinate synthetase gene expression. FEBS J. 2007, 274:5250-5262.
9. Cen B., Deguchi A., Weinstein I.B. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1. Cancer Res. 2008, 68:5355-5362.
10. Chan J., Prado-Lourenco L., Khachigian L.M., Bennett M.R., Di Bartolo B.A., Kavurma M.M. TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner. Circ. Res. 2010, 106:1061-1071.
11. Chen X., Zhao Y., Guo Z., Zhou L., Okoro E.U., Yang H. Transcriptional regulation of ATP-binding cassette transporter A1 expression by a novel signaling pathway. J. Biol. Chem. 2011, 286:8917-8923.
12. Chu S., Ferro T.J. Identification of a hydrogen peroxide-induced PP1-JNK1-Sp1 signaling pathway for gene regulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L983-L992.
13. Chu S., Blaisdell C.J., Liu M.Z., Zeitlin P.L. Perinatal regulation of the ClC-2 chloride channel in lung is mediated by Sp1 and Sp3. Am. J. Physiol. 1999, 276:L614-L624.
14. Chu S., Cockrell C.A., Ferro T.J. Expression of alpha-ENaC2 is dependent on an upstream Sp1 binding motif and is modulated by protein phosphatase 1 in lung epithelial cells. Biochem. Biophys. Res. Commun. 2003, 303:1159-1168.
15. Chuang J.Y., Wang Y.T., Yeh S.H., Liu Y.W., Chang W.C., Hung J.J. Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol. Biol. Cell 2008, 19:1139-1151.
16. Chun R.F., Semmes O.J., Neuveut C., Jeang K.T. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 1998, 72:2615-2629.
17. Chupreta S., Du M., Todisco A., Merchant J.L. EGF stimulates gastrin promoter through activation of Sp1 kinase activity. Am. J. Physiol. Cell Physiol. 2000, 278:C697-C708.
18. Cieslik K., Lee C.M., Tang J.L., Wu K.K. Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A. J. Biol. Chem. 1999, 274:34669-34675.
19. Cook T., Gebelein B., Urrutia R. Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann. N. Y. Acad. Sci. 1999, 880:94-102.
20. Courey A.J., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 1988, 55:887-898.
21. Courey A.J., Holtzman D.A., Jackson S.P., Tjian R. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 1989, 59:827-836.
22. D'Addario M., Arora P.D., McCulloch C.A. Role of p38 in stress activation of Sp1. Gene 2006, 379:51-61.
23. Daniel S., Zhang S., DePaoli-Roach A.A., Kim K.H. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J. Biol. Chem. 1996, 271:14692-14697.
24. Dufau M.L., Liao M., Zhang Y. Participation of signaling pathways in the derepression of luteinizing hormone receptor transcription. Mol. Cell. Endocrinol. 2010, 314:221-227.
25. Dunzendorfer S., Lee H.K., Tobias P.S. Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ. Res. 2004, 95:684-691.
26. Dwivedi P.P., et al. A role for the phosphatidylinositol 3-kinase-protein kinase C zeta-Sp1 pathway in the 1,25-dihydroxyvitamin D3 induction of the 25-hydroxyvitamin D3 24-hydroxylase gene in human kidney cells. Cell. Signal. 2010, 22:543-552.
27. Dynan W.S., Tjian R. Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 1983, 32:669-680.
28. Fernandez-Alvarez A., Tur G., Lopez-Rodas G., Casado M. Reciprocal regulation of the human sterol regulatory element binding protein (SREBP)-1a promoter by Sp1 and EGR-1 transcription factors. FEBS Lett. 2008, 582:177-184.
29. Fojas d.B., Collins N.K., Du P., Azizkhan-Clifford J., Mudryj M. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 2001, 20:5737-5747.
30. Garcia A., Cereghini S., Sontag E. Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of Sp1-responsive promoters. J. Biol. Chem. 2000, 275:9385-9389.
31. Ge Y., Jensen T.L., Matherly L.H., Taub J.W. Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines. Blood 2003, 101:1551-1557.
32. Georgescu M.M. PTEN tumor suppressor network in PI3K-Akt pathway control. Genes & Cancer 2010, 1:1170-1177.
33. Guo L., Eviatar-Ribak T., Miskimins R. Sp1 phosphorylation is involved in myelin basic protein gene transcription. J. Neurosci. Res. 2010, 88:3233-3242.
34. Haidweger E., Novy M., Rotheneder H. Modulation of Sp1 activity by a cyclin A/CDK complex. J. Mol. Biol. 2001, 306:201-212.
35. Hammoud L., Burger D.E., Lu X., Feng Q. Tissue inhibitor of metalloproteinase-3 inhibits neonatal mouse cardiomyocyte proliferation via EGFR/JNK/SP-1 signaling. Am. J. Physiol. Cell Physiol. 2009, 296:C735-C745.
36. Harris S.M., Harvey E.J., Hughes T.R., Ramji D.P. The interferon-gamma-mediated inhibition of lipoprotein lipase gene transcription in macrophages involves casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3. Cell. Signal. 2008, 20:2296-2301.
37. Horovitz-Fried M., Sampson S.R. Involvement of PKCalpha in insulin-induced PKCdelta expression: importance of SP-1 and NFkappaB transcription factors. Biochem. Biophys. Res. Commun. 2007, 352:78-83.
38. Hsu M.C., Chang H.C., Hung W.C. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J. Biol. Chem. 2006, 281:4718-4725.
39. Huang P.H., Wang D., Chuang H.C., Wei S., Kulp S.K., Chen C.S. alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis. Carcinogenesis 2009, 30:1125-1131.
40. Imayama I., et al. Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1. Hypertension 2008, 51:1631-1636.
41. Iwahori S., et al. Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein. J. Virol. 2007, 81:9653-9664.
42. Iwahori S., et al. Identification of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites. Cell. Signal. 2008, 20:1795-1803.
43. Jackson S.P., MacDonald J.J., Lees-Miller S., Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 1990, 63:155-165.
44. Jeang K.T., Chun R., Lin N.H., Gatignol A., Glabe C.G., Fan H. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 1993, 67:6224-6233.
45. Juang Y.T., et al. Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus. J. Biol. Chem. 2011, 286:1795-1801.
46. Kang-Park S., Lee J.H., Shin J.H., Lee Y.I. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings. Biochem. Biophys. Res. Commun. 2001, 283:303-307.
47. Kang-Park S., Lee Y.I., Lee Y.I. PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cells. FEBS Lett. 2003, 545:203-208.
48. Kim D.B., DeLuca N.A. Phosphorylation of transcription factor Sp1 during herpes simplex virus type 1 infection. J. Virol. 2002, 76:6473-6479.
49. Kim H.S., Lim I.K. Phosphorylated extracellular signal-regulated protein kinases 1 and 2 phosphorylate Sp1 on serine 59 and regulate cellular senescence via transcription of p21Sdi1/Cip1/Waf1. J. Biol. Chem. 2009, 284:15475-15486.
50. Kim J.I., Cordova A.C., Hirayama Y., Madri J.A., Sumpio B.E. Differential effects of shear stress and cyclic strain on Sp1 phosphorylation by protein kinase Czeta modulates membrane type 1-matrix metalloproteinase in endothelial cells. Endothelium 2008, 15:33-42.
51. Lacroix I., Lipcey C., Imbert J., Kahn-Perles B. Sp1 transcriptional activity is up-regulated by phosphatase 2A in dividing T lymphocytes. J. Biol. Chem. 2002, 277:9598-9605.
52. Lam J.K., Matsubara S., Mihara K., Zheng X.L., Mooradian A.D., Wong N.C. Insulin induction of apolipoprotein AI, role of Sp1. Biochemistry 2003, 42:2680-2690.
53. Law A.Y., Yeung B.H., Ching L.Y., Wong C.K. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29. J. Cell. Biochem. 2011, 112:2089-2096.
54. Lee S., Park U., Lee Y.I. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites. Virology 2001, 283:167-177.
55. Leggett R.W., Armstrong S.A., Barry D., Mueller C.R. Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J. Biol. Chem. 1995, 270:25879-25884.
56. Li T., Bai L., Li J., Igarashi S., Ghishan F.K. Sp1 is required for glucose-induced transcriptional regulation of mouse vesicular glutamate transporter 2 gene. Gastroenterology 2008, 134:1994-2003.
57. Li Z.Y., et al. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549. Tumour Biol. 2011, 32:677-687.
58. Liao M., Zhang Y., Dufau M.L. Protein kinase Calpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites. Mol. Endocrinol. 2008, 22:1449-1463.
59. Lin M.C., et al. Shear stress induction of the tissue factor gene. J. Clin. Invest. 1997, 99:737-744.
60. Lin H.H., Lai S.C., Chau L.Y. Heme oxygenase-1/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1. J. Biol. Chem. 2011, 286:3829-3838.
61. Loregian A., et al. The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein. J. Cell. Physiol. 2003, 196:251-257.
62. Lu X.F., et al. Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation. Cell. Mol. Life Sci. 2010, 67:3313-3329.
63. Majumdar G., et al. Insulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cells. J. Biol. Chem. 2006, 281:3642-3650.
64. Marin M., Karis A., Visser P., Grosveld F., Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 1997, 89:619-628.
65. Milanini-Mongiat J., Pouyssegur J., Pages G. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J. Biol. Chem. 2002, 277:20631-20639.
66. Nemoto T., Yanagita T., Kanai T., Wada A. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: the role of GSK-3beta in the maintenance of steady-state levels of insulin receptor signaling molecules and Na(v)1.7 sodium channel in adrenal chromaffin cells. J. Pharmacol. Sci. 2009, 109:157-161.
67. Niina I., et al. DNA topoisomerase inhibitor, etoposide, enhances GC-box-dependent promoter activity via Sp1 phosphorylation. Cancer Sci. 2007, 98:858-863.
68. Olofsson B.A., Kelly C.M., Kim J., Hornsby S.M., zizkhan-Clifford J. Phosphorylation of Sp1 in response to DNA damage by ataxia telangiectasia-mutated kinase. Mol. Cancer Res. 2007, 5:1319-1330.
69. Pages G. Sp3-mediated VEGF regulation is dependent on phosphorylation by extra-cellular signals regulated kinases (Erk). J. Cell. Physiol. 2007, 213:454-463.
70. Pal S., Claffey K.P., Cohen H.T., Mukhopadhyay D. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J. Biol. Chem. 1998, 273:26277-26280.
71. Pallas D.C., et al. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 1990, 60:167-176.
72. Pascal E., Tjian R. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 1991, 5:1646-1656.
73. Philipsen S., Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999, 27:2991-3000.
74. Pore N., et al. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell 2004, 15:4841-4853.
75. Rajcani J., Andrea V., Ingeborg R. Peculiarities of herpes simplex virus (HSV) transcription: an overview. Virus Genes 2004, 28:293-310.
76. Rankin S.L., Guy C.S., Mearow K.M. PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1. Biochem. Biophys. Res. Commun. 2009, 379:721-725.
77. Reisinger K., Kaufmann R., Gille J. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J. Cell Sci. 2003, 116:225-238.
78. Rohlff C., Ahmad S., Borellini F., Lei J., Glazer R.I. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. Biol. Chem. 1997, 272:21137-21141.
79. Rojo A.I., et al. Regulation of heme oxygenase-1 gene expression through the phosphatidylinositol 3-kinase/PKC-zeta pathway and Sp1. Free Radic. Biol. Med. 2006, 41:247-261.
80. Rossi A., Mukerjee R., Ferrante P., Khalili K., Amini S., Sawaya B.E. Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. J. Gen. Virol. 2006, 87:1613-1623.
81. Schafer D., Hamm-Kunzelmann B., Brand K. Glucose regulates the promoter activity of aldolase A and pyruvate kinase M2 via dephosphorylation of Sp1. FEBS Lett. 1997, 417:325-328.
82. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 2003, 3:155-168.
83. Spengler M.L., Guo L.W., Brattain M.G. Phosphorylation mediates Sp1 coupled activities of proteolytic processing, desumoylation and degradation. Cell Cycle 2008, 7:623-630.
84. Sze K.M., Wong K.L., Chu G.K., Lee J.M., Yau T.O., Ng I.O. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology 2011, 53:1558-1569.
85. Tan N.Y., et al. Angiotensin II-inducible platelet-derived growth factor-D transcription requires specific Ser/Thr residues in the second zinc finger region of Sp1. Circ. Res. 2008, 102:e38-e51.
86. Tsai P.F., et al. Interplay between PKCdelta and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. J. Virol. 2011, 85:2373-2385.
87. Vicart A., Lefebvre T., Imbert J., Fernandez A., Kahn-Perles B. Increased chromatin association of Sp1 in interphase cells by PP2A-mediated dephosphorylations. J. Mol. Biol. 2006, 364:897-908.
88. Vlach J., Garcia A., Jacque J.M., Rodriguez M.S., Michelson S., Virelizier J.L. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology 1995, 208:753-761.
89. Wang Z., Zhang Y., Lu J., Sun S., Ravid K. Mpl ligand enhances the transcription of the cyclin D3 gene: a potential role for Sp1 transcription factor. Blood 1999, 93:4208-4221.
90. Wang Y.T., Chuang J.Y., Shen M.R., Yang W.B., Chang W.C., Hung J.J. Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process. J. Mol. Biol. 2008, 380:869-885.
91. Wang Y.T., Yang W.B., Chang W.C., Hung J.J. Interplay of Posttranslational Modifications in Sp1 Mediates Sp1 Stability during Cell Cycle Progression. J. Mol. Biol. 2011, 414:1-14.
92. Wei S., et al. Thiazolidinediones mimic glucose starvation in facilitating Sp1 degradation through the up-regulation of beta-transducin repeat-containing protein. Mol. Pharmacol. 2009, 76:47-57.
93. Wildeman A.G. Regulation of SV40 early gene expression. Biochem. Cell Biol. 1988, 66:567-577.
94. Wu C.C., et al. Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPalpha. Mol. Cancer Ther. 2008, 7:1365-1375.
95. Xu K., Shu H.K. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res. 2007, 67:6121-6129.
96. Xu K., Chang C.M., Gao H., Shu H.K. Epidermal growth factor-dependent cyclooxygenase-2 induction in gliomas requires protein kinase C-delta. Oncogene 2009, 28:1410-1420.
97. Yang S.I., Lickteig R.L., Estes R., Rundell K., Walter G., Mumby M.C. Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol. Cell. Biol. 1991, 11:1988-1995.
98. Yun S., et al. Transcription factor Sp1 phosphorylation induced by shear stress inhibits membrane type 1-matrix metalloproteinase expression in endothelium. J. Biol. Chem. 2002, 277:34808-34814.
99. Zhang Y., Liao M., Dufau M.L. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. Mol. Cell. Biol. 2006, 26:6748-6761.
100. Zhang Y., Liao M., Dufau M.L. Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release. J. Biol. Chem. 2008, 283:24039-24046.
101. Zhang L., Yang G., Tang G., Wu L., Wang R. Rat pancreatic level of cystathionine gamma-lyase is regulated by glucose level via specificity protein 1 (SP1) phosphorylation. Diabetologia 2011, 54:2615-2625.
102. Zheng X.L., Matsubara S., Diao C., Hollenberg M.D., Wong N.C. Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1. J. Biol. Chem. 2001, 276:13822-13829.